JESSI GREEN: Open Payments
NPI 1972193886 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$995 in 57 payments from 12 companies in 2025. Trend: 2023 $340 · 2024 $1,212 · 2025 $995
Food & beverage: $995
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $259 |
| Novo Nordisk Inc | 8 | $145 |
| Astellas Pharma US Inc | 6 | $106 |
| PFIZER INC. | 6 | $97 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $93 |
| MILLICENT US INC | 4 | $72 |
| Lilly USA, LLC | 4 | $62 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| Exeltis, USA Inc. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
Products named: UBRELVY, Veozah, VRAYLAR, NURTEC ODT, Wegovy, MOUNJARO, Ozempic, MYFEMBREE.
Industry payments across IN — which companies pay providers there.
